Watch Wegovy Weight-Loss Pill: Novo CEO Says No Intention to Lower Prices Further - Bloomberg

May 6th, 2026

Novo CEO Says No Intention to Lower Wegovy Prices Further

Novo Nordisk CEO Mike Doustdar discusses the drugmaker's Wegovy obesity pill which fueled sales in the first quarter. Novo is "very optimistic" on the medication despite competition from Eli Lilly, Doustdar tells Bloomberg Television, and the firm doesn't anticipate any price reductions.

Top Video

Duration:2:50

BlackRock's Rieder Says Equities Aren't in a Bubble, Fed on Hold

Duration:1:48

Trump’s Latest 10% Global Tariffs Ruled Unlawful by US Trade Court

Duration:1:53

Jobs Report Locks in Fed Stalemate, PGIM's Collins Says

Surveillance

Duration:46:40

Scaramucci: My Buddies Regret Picking Trump

Duration:2:03

US Jobs Data ‘Steady as It Goes,’ Says BlackRock’s Rosenberg

Duration:1:12

SoftBank Cuts Target for OpenAI Margin Loan

Duration:1:34

Earnings Resilience Amid Iran Risk: Markets Snapshot

The Opening Trade

Duration:3:32

Starmer Faces Heavy Losses in Local Election

The Opening Trade

Duration:5:01

Oil Market Completely Broken, Vanda Insights Says

Duration:8:46

Commerzbank Steps Up UniCredit Defense

The Opening Trade

Duration:2:02

Wayve CEO on Tesla, Waymo, Future of Self-Driving Cars

Duration:4:10

China's Growing Anxiety Over Iran

Available on:

Listen onApple TV Listen onRoku Listen onSamsung TV Listen onFire TV Listen onAndroid TV Listen onRakuten TV Listen onHaystack News

Watch BTV in your area: